Raloxifene Acutely Relaxes Rabbit Coronary Arteries In Vitro by an Estrogen Receptor–Dependent and Nitric Oxide–Dependent Mechanism
- 7 September 1999
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 100 (10) , 1095-1101
- https://doi.org/10.1161/01.cir.100.10.1095
Abstract
Background —Selective estrogen receptor modulators (SERMs) have been defined as compounds that display tissue specificity with regard to estrogenic effects. They appear to share the beneficial effects of estrogen on bone and lipids but are not associated with an increased risk of breast or uterine carcinoma. Estrogen relaxes coronary arteries and has long-term protective effects on the vascular system. The effect of SERMs on the coronary vasculature is unknown. We therefore investigated the effects of the SERM raloxifene on isolated rabbit coronary arteries. Methods and Results —–Rings of coronary artery from adult male and nonpregnant female New Zealand White rabbits were suspended in organ baths containing Krebs solution; isometric tension was then measured. Raloxifene induced coronary arterial relaxation in male and female coronary arteries by an endothelium-dependent and estrogen receptor–dependent mechanism involving nitric oxide. Raloxifene also had a direct calcium antagonistic effect on the coronary myocyte. Estrogen, however, induced only endothelium-independent coronary arterial relaxation. The endothelium-dependent component of relaxation induced by raloxifene 10 −6 mol/L resulted in almost 100% (79±7% versus 43±3%, P −6 mol/L. Conclusions —These data demonstrate that raloxifene has vascular relaxing properties. The surprising finding is that the receptor-dependent effects via the endothelium are observed in coronary arteries from both male and female animals.Keywords
This publication has 40 references indexed in Scilit:
- Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal WomenNew England Journal of Medicine, 1997
- Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- A PROPOSED MECHANISM FOR THE CARDIOPROTECTIVE EFFECT OF OESTROGEN IN WOMEN: ENHANCED ENDOTHELIAL NITRIC OXIDE RELEASE DECREASES CORONARY ARTERY REACTIVITYClinical and Experimental Pharmacology and Physiology, 1996
- Mechanisms of estrogen-induced vasodilation: In vivo studies in canine coronary conductance and resistance arteriesJournal of the American College of Cardiology, 1995
- Raloxifene is a Tissue‐Selective Agonist/Antagonist That Functions through the Estrogen ReceptorAnnals of the New York Academy of Sciences, 1995
- Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.Journal of Clinical Investigation, 1994
- Endothelium independent relaxation of human coronary arteries by 17 -oestradiol in vitroCardiovascular Research, 1993
- L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxationBiochemical and Biophysical Research Communications, 1988
- Menopause and the Risk of Coronary Heart Disease in WomenNew England Journal of Medicine, 1987